Subgenomic particles in rAAV vectors result from DNA lesion/break and non-homologous end joining of vector genomes
Recombinant adeno-associated virus (rAAV) vectors have been developed for therapeutic treatment of genetic diseases. Current rAAV vectors administered to affected individuals often contain vector DNA-related contaminants. Here we present a thorough molecular analysis of the configuration of non-stan...
Saved in:
Main Authors: | Junping Zhang (Author), Ping Guo (Author), Xiangping Yu (Author), Dylan A. Frabutt (Author), Anh K. Lam (Author), Patrick L. Mulcrone (Author), Matthew Chrzanowski (Author), Jenni Firrman (Author), Derek Pouchnik (Author), Nianli Sang (Author), Yong Diao (Author), Roland W. Herzog (Author), Weidong Xiao (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Controlled Release of rAAV Vectors from APMA-Functionalized Contact Lenses for Corneal Gene Therapy
by: Fernando Alvarez-Rivera, et al.
Published: (2020) -
Advanced Characterization of DNA Molecules in rAAV Vector Preparations by Single-stranded Virus Next-generation Sequencing
by: Emilie Lecomte, et al.
Published: (2015) -
Robust Long-term Transduction of Common Marmoset Neuromuscular Tissue With rAAV1 and rAAV9
by: Hironori Okada, et al.
Published: (2013) -
rAAV-delivered PTEN therapeutics for prostate cancer
by: Jianzhong Ai, et al.
Published: (2022) -
AAV gene therapy vectors in the TMJ
by: Sabine M. Brouxhon, et al.
Published: (2022)